Tenon Medical (TNON) EBIT (2021 - 2026)

Tenon Medical's EBIT history runs 6 years deep, the most recent figure standing at -$3.3 million for Q1 2026.

• On a quarterly basis, EBIT rose 10.8% year-over-year to -$3.3 million in Q1 2026; TTM through Mar 2026 was -$12.4 million, a 11.06% increase from a year earlier, with the FY2025 full-year figure at -$12.8 million, up 7.08% from the prior year.
• EBIT retreated to -$3.3 million in Q1 2026 per TNON's latest filing, from -$2.9 million in the prior quarter.
• Across five years, EBIT topped out at -$2.1 million in Q1 2022 and bottomed at -$7.9 million in Q4 2022.
• The 5-year median for EBIT is -$3.4 million (2023), against an average of -$3.8 million.
• Across the five-year window, EBIT tumbled 1000.0% in 2022 and soared 60.38% in 2023, its largest moves.
• Year by year, EBIT stood at -$7.9 million in 2022, then surged by 60.38% to -$3.1 million in 2023, then retreated by 1.02% to -$3.2 million in 2024, then gained by 9.68% to -$2.9 million in 2025, then declined by 14.45% to -$3.3 million in 2026.
• Per Business Quant, the three latest TNON EBIT figures stand at -$3.3 million (Q1 2026), -$2.9 million (Q4 2025), and -$3.4 million (Q3 2025).